Quality · Distribution
Recalling a batch you have already exported: what the guidelines say
When an exported batch is recalled, the distributor follows the recall message, informs the manufacturer and the regulators of every country supplied, and secures and segregates stock. It relies on distribution records naming customers, batches and quantities. The recall is documented to a final report, and the arrangements are checked at least annually.
Why does a recall matter once a batch has left your country?
Because the batch is now in a supply chain you do not run, and the people who can trace it are your distributors. Recall guidance is written for distributors, but a manufacturer depends on it: the original manufacturer or marketing authorisation holder is the party who must be informed (WHO Technical Report Series No. 1025, Annex 7, section 10.3).2 This is not legal advice for any country.
What do the guidelines require when a recall starts?
They require a written procedure that works promptly. WHO Technical Report Series No. 1025, Annex 7, section 10.1 asks for a written procedure, in compliance with national or regional requirements, to recall medical products effectively and promptly.2 The European Commission's Good Distribution Practice guidelines (2013/C 343/01), section 6.5, add that recall operations should be capable of being initiated promptly and at any time, and that the distributor must follow the instructions of a recall message, approved if required by the competent authorities.1
Notification runs outward. WHO section 10.4 says information on a recall should be shared with the appropriate national or regional regulatory authority, and section 10.6 says all customers and competent authorities of all countries to which the product may have been distributed should be informed promptly.2 For temperature-sensitive products, WHO Technical Report Series No. 961, Annex 9, section 8.6.2 also lists notifying overseas regulatory counterparts where the product has been exported.4
What distribution records make a recall possible?
The EU guidelines say distribution records should be readily accessible to the person responsible for the recall and contain sufficient information on distributors and directly supplied customers: addresses, phone or fax numbers inside and outside working hours, batch numbers at least for products bearing safety features, and quantities delivered, including for exported products and samples.1 WHO section 10.7 describes the same content: name, address, contact detail, batch numbers, quantities and safety features, including exported products.2
In practice this means a manufacturer should ask, before the first shipment, whether a distributor can produce a customer list by batch within hours. That is common industry practice, not a quoted rule. For how to assess a partner more broadly, see how to qualify a distributor.
How should recalled product be handled?
It should be secured, segregated and clearly labelled. WHO section 10.5 says recalled products should be secure, segregated, transported and stored under appropriate conditions, clearly labelled as recalled, with the product's storage conditions maintained where possible.2 For temperature-sensitive products, WHO Technical Report Series No. 961, Annex 9, section 6.12.2 says recalled products should be marked as "recalled" or "withdrawn" and transported back from the recipient and quarantined under secure conditions pending a final decision on disposal.4 See also cold chain at the border.
Do the guidelines require a mock recall?
No, and this is often misquoted online. Section 6.5 of the EU guidelines says: "The effectiveness of the arrangements for product recall should be evaluated regularly (at least annually)."1 WHO section 10.2 says: "The effectiveness of the procedure should be checked annually and updated as necessary."2
Both texts ask for the arrangements or the procedure to be evaluated. Neither says a test recall of real product must be run. The documents quoted here do not prescribe a method for the evaluation; they require that it happens, at least once a year.
How is a recall closed?
With a record and a reconciliation. The EU guidelines say any recall operation should be recorded at the time it is carried out, with records readily available to the competent authorities, and that progress should be recorded for a final report.1 WHO section 10.8 adds that the final report should include a reconciliation between delivered and recovered quantities.2
How do complaints and suspected falsified product fit in?
They are often where a recall begins. WHO section 8 asks for a written complaint procedure, with every complaint recorded and investigated, the root cause identified, the impact on other batches assessed, and information shared with the national regulatory authority and a recall initiated where appropriate.2 The EU guidelines, section 6.4, say wholesale distributors must immediately inform the competent authority and the marketing authorisation holder of any product they identify as falsified or suspect to be falsified, and that such product should be physically segregated in a dedicated area.1 WHO Technical Report Series No. 1019, Annex 5, section 7.7 asks national regulators to notify other authorities and the WHO Global Surveillance and Monitoring System of confirmed cases of imported substandard or falsified products.3
What should a manufacturer agree with a distributor before shipping?
Agree who tells whom, and how fast. The guidance above implies several points worth writing into an agreement: who receives complaints, who decides on a recall, how the manufacturer is told, how the distributor will notify customers and authorities, and who holds recalled stock. These are practical suggestions drawn from common industry practice, and the contents of a distribution agreement are covered in distribution agreement essentials.
Local recall requirements differ by country, and WHO section 10.1 itself says the procedure should comply with national or regional requirements. For the Republic of Yemen, those specifics are confirmed case by case rather than set out here.
Frequently asked questions
What must a distributor do when an exported pharmaceutical batch is recalled?
The distributor follows the recall message, informs the original manufacturer or marketing authorisation holder, and informs customers and competent authorities in every country supplied (WHO TRS 1025, Annex 7, section 10). It segregates and labels recalled stock, uses its distribution records to trace customers, and records progress to a final report that reconciles delivered and recovered quantities.
Do the EU Good Distribution Practice guidelines require a mock recall?
No. Chapter 6.5 of the European Commission guidelines of 5 November 2013 (2013/C 343/01) says the effectiveness of the arrangements for product recall should be evaluated regularly, at least annually. It does not say a test recall of real product must be run. The requirement is often misquoted online.
What records does a distributor need to run a recall?
Distribution records must be readily accessible to the person responsible for the recall. WHO TRS 1025, Annex 7, section 10.7 lists customer name, address, contact details, batch numbers, quantities and safety features, including for exported products. The EU guidelines add phone numbers inside and outside working hours.
Who must be told when an exported product is recalled?
WHO TRS 1025, Annex 7, says the original manufacturer or marketing authorisation holder must be informed, information shared with the relevant national or regional authority, and all customers and competent authorities of all countries to which the product may have been distributed informed promptly.
References
- European Commission, Guidelines of 5 November 2013 on Good Distribution Practice of medicinal products for human use (2013/C 343/01), Chapter 6. Accessed 3 October 2026. eur-lex.europa.eu
- WHO, Good storage and distribution practices for medical products, WHO Technical Report Series No. 1025, Annex 7 (2020), sections 8 and 10. Accessed 3 October 2026. cdn.who.int
- WHO, Guidelines on import procedures for medical products, WHO Technical Report Series No. 1019, Annex 5 (2019), section 7. Accessed 3 October 2026. cdn.who.int
- WHO, Model guidance for the storage and transport of time and temperature sensitive pharmaceutical products, WHO Technical Report Series No. 961, Annex 9 (2011), sections 6.12.2 and 8.6.2. Accessed 3 October 2026. who.int